Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities
Phase 2 clinical trial data published in the New England Journal of Medicine in 2023 demonstrated substantial mean reductions in body weight in some participants exceeding 20% over 48 weeks alongside improvements in glycaemic control and cardiometabolic markers
[1] Martello E et al
Preliminary data suggests that this combination is highly effective in promoting weight loss in obese patients with type 2 diabetes in addition to being effective in lowering HbA1c levels [10]
US$ 25.77
US$ 29.38
US$ 23.18
